Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.4, 2005-01, pp. : 231-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-term Treatment with a Low Dose of Inhaled Fluticasone Propionate Decreases the Number of CD1a+ Dendritic Cells in Asthmatic Airways

By Bocchino V. Bertorelli G. Zhuo X. Grima P. Di Comite V. Damia R. Chetta A. del Donno M. Foresi A. Casalini A. Testi R. Olivieri D.

Pulmonary Pharmacology & Therapeutics, Vol. 10, Iss. 5, 1997-05 ,pp. : 253-259

Academic Press

Access to resources Recommend Favorite

Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskus or Pressurised Metered-Dose Inhaler in Children with Asthma

By Teresa Bracamonte

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Salmeterol/Fluticasone Propionate Combination

By Spencer C.M. Jarvis B.

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 933-940

Adis International

Access to resources Recommend Favorite

Comparison of Salmeterol/Fluticasone Propionate Combination with Budesonide in Patients with Mild-to-Moderate Asthma

By Johansson G.

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 633-642

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate superior in COPD

Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite